NDC 13533-618

HYPERRAB S/D

Rabies Immune Globulin (human)

HYPERRAB S/D is a Intramuscular Injection in the Plasma Derivative category. It is labeled and distributed by Grifols Usa, Llc. The primary component is Human Rabies Virus Immune Globulin.

Product ID13533-618_162cf60b-ab94-4762-bdb3-b975001043eb
NDC13533-618
Product TypePlasma Derivative
Proprietary NameHYPERRAB S/D
Generic NameRabies Immune Globulin (human)
Dosage FormInjection
Route of AdministrationINTRAMUSCULAR
Marketing Start Date1996-08-14
Marketing CategoryBLA / BLA
Application NumberBLA101144
Labeler NameGRIFOLS USA, LLC
Substance NameHUMAN RABIES VIRUS IMMUNE GLOBULIN
Active Ingredient Strength150 [iU]/mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 13533-618-02

1 VIAL, GLASS in 1 CARTON (13533-618-02) > 2 mL in 1 VIAL, GLASS (13533-618-20)
Marketing Start Date1996-08-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 13533-618-02 [13533061802]

HYPERRAB S/D INJECTION
Marketing CategoryBLA
Application NumberBLA101144
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date1996-08-14

NDC 13533-618-20 [13533061820]

HYPERRAB S/D INJECTION
Marketing CategoryBLA
Application NumberBLA101144
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2012-11-29

NDC 13533-618-11 [13533061811]

HYPERRAB S/D INJECTION
Marketing CategoryBLA
Application NumberBLA101144
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date2012-11-29

NDC 13533-618-10 [13533061810]

HYPERRAB S/D INJECTION
Marketing CategoryBLA
Application NumberBLA101144
Product TypePLASMA DERIVATIVE
Billing UnitML
Marketing Start Date1996-08-14

Drug Details

Active Ingredients

IngredientStrength
HUMAN RABIES VIRUS IMMUNE GLOBULIN150 [iU]/mL

NDC Crossover Matching brand name "HYPERRAB S/D" or generic name "Rabies Immune Globulin (human)"

NDCBrand NameGeneric Name
13533-318HyperRABRabies Immune Globulin (Human)
13533-618HYPERRABRABIES IMMUNE GLOBULIN (HUMAN)

Trademark Results [HYPERRAB]

Mark Image

Registration | Serial
Company
Trademark
Application Date
HYPERRAB
HYPERRAB
78622898 3206857 Live/Registered
GRIFOLS THERAPEUTICS LLC
2005-05-04

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.